Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 24, 2015

View Archived Issues

Super NK cells kill tumor cells in lymph nodes

Transgenic zebra finches expressing mutant huntingtin develop vocal dysfunction

Romidepsin and Bionor's HIV vaccine Vacc-4x achieves primary endpoint in phase I/II trial

Bayer and CRISPR Therapeutics to develop potential cures for genetic diseases

Biosimilar adalimumab M-923 met primary endpoint in pharmacokinetic study

Acacia Pharma releases promising data from second pivotal phase III study of Baremsis for PONV

Mirati opens phase II trial of glesatinib, signs collaborative agreements for companion diagnostics

Alexza reports interim results from phase IIa trial of inhaled alprazolam in epilepsy

Loxo Oncology enrolls first patient in phase I trial of LOXO-101

Kiadis forms collaboration with Thalassaemia International Federation

Lilly and Halozyme to develop Enhanze subcutaneous formulations

Medidur prevents recurrence of posterior uveitis in phase III trial

Amicus Therapeutics to begin phase I/II study of ATB-200

Novoron Bioscience receives grant to evaluate new treatments for multiple sclerosis

Cantabio Pharmaceuticals and Gardedam Therapeutics complete merger

Astellas Pharma patents muscarinic M3 receptor PAMs

Tamoxifen metabolite (Z)-endoxifen active against metastatic breast cancer in trial

Novartis describes nonsense mutation suppressors

Esteve presents dual sigma1R/MOR-1 ligands

Emulate expands collaboration with Merck & Co. to use Organ-Chips in drug discovery

Merck & Co. develops sGC activators

Roche reports oxytocin agonists

Phase I trial of Panacela's cancer vaccine Mobilan underway in patients with prostate cancer

EMA confirms that MAA for AcelRx's sublingual sufentanil can use centralized procedure

SARM AUSRM-057 shows potential for colorectal cancer-associated cachexia

Cellectis seeks clearance to start first-in-human trial of UCART-19

Immuron updates on development of Clostridium difficile therapeutic IMM-529

Paclitaxel trevatide shows activity in patients with breast cancer and CNS metastases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...